NSRX logo

Nasus Pharma Ltd.

NSRX
Healthcare|Medical - Pharmaceuticals|IL
$2.82
-0.09 (-3.09%)
DCF Value
$0.06
Tangible Book / Share
$0.99
Cash / Share
$1.07
Next Earnings Report
Mar 3, 2027
EPS est. -$0.67
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Sep 18, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (1)

Jan 2027
Est. completion
P1Chemotherapy-Induced Nausea and Vomiting (CINV)
A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults
NCT07868861n=12

Recent Press Releases

Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron
Sep 29, 2026 · GlobeNewsWire
Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis
Sep 14, 2026 · GlobeNewsWire
Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026 · GlobeNewsWire
Nasus Pharma Announces Transition of Chief Financial Officer
Aug 19, 2026 · GlobeNewsWire
Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
Aug 17, 2026 · GlobeNewsWire

SEC Filings (69)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 19, 2026S-8Employee stock planDocumentIndex
Oct 8, 20266-KForeign issuer reportDocumentIndex
Sep 18, 2026424B5Offering prospectusDocumentIndex
Sep 18, 20266-KForeign issuer reportDocumentIndex
Sep 14, 20266-KForeign issuer reportDocumentIndex
Sep 11, 2026EFFECTDocumentIndex
Sep 4, 20266-KForeign issuer reportDocumentIndex
Sep 1, 2026F-3Shelf registrationDocumentIndex
Aug 20, 2026EFFECTDocumentIndex
Aug 19, 20266-KForeign issuer reportDocumentIndex
Aug 19, 2026POS AMDocumentIndex
Aug 17, 20266-KForeign issuer reportDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 28, 20266-KForeign issuer reportDocumentIndex
Jun 9, 20266-KForeign issuer reportDocumentIndex
May 26, 2026S-8Employee stock planDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 31, 2026EFFECTDocumentIndex
Mar 27, 2026POS AMDocumentIndex
Mar 25, 20266-KForeign issuer reportDocumentIndex
Mar 25, 202620-FAnnual report (foreign)DocumentIndex
Mar 16, 20266-KForeign issuer reportDocumentIndex
Mar 13, 2026EFFECTDocumentIndex
Mar 6, 20266-KForeign issuer reportDocumentIndex
Mar 4, 20266-KForeign issuer reportDocumentIndex
Mar 2, 2026F-1IPO / offering registrationDocumentIndex
Feb 25, 2026DDocumentIndex
Feb 24, 20266-KForeign issuer reportDocumentIndex
Feb 13, 20266-KForeign issuer reportDocumentIndex
Feb 12, 20266-KForeign issuer reportDocumentIndex
Jan 29, 20266-KForeign issuer reportDocumentIndex
Jan 20, 20266-KForeign issuer reportDocumentIndex
Dec 29, 20256-KForeign issuer reportDocumentIndex
Dec 22, 20256-KForeign issuer reportDocumentIndex
Nov 20, 20256-KForeign issuer reportDocumentIndex
Nov 18, 20256-KForeign issuer reportDocumentIndex
Nov 13, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 12, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 10, 2025SC 13GPassive 5%+ stakeDocumentIndex